US Patent Issued on July 22 for "Pharmaceutical process for the preparation of 4-{4-[(3R)-3-methylmorpholin-4-yl-6-[1-((R)-S-methylsulfonimidoyl) cyclopropylpyrimidin-2-yl}-1H-pyrrolo[2,3-b pyridine and intermediates" (British Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,678, issued on July 22.

"Pharmaceutical process for the preparation of 4-{4-[(3R)-3-methylmorpholin-4-yl-6-[1-((R)-S-methylsulfonimidoyl) cyclopropylpyrimidin-2-yl}-1H-pyrrolo[2,3-b pyridine and intermediates" was invented by Mark Andrew Graham (Cambridge, Great Britain), Lucinda Victoria Jackson (Cambridge, Great Britain), Gary Michael Noonan (Cambridge, Great Britain), Phillip Anthony Inglesby (Cambridge, Great Britain), David Pranay Dave (Cambridge, Great Britain) and Katie Grace Cooper (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure concerns the large-scale manufacture of pharmaceutical compounds, ...